Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuangyu granules for influenza (wind-heat attacking wei syndrome)
CTR20192581Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shuangyu granules in influenza, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Jan 2020; status: completed.
02
Drugs
shuangyu granules
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20192581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192581.